financetom
Business
financetom
/
Business
/
Market Chatter: Silgan's Bid to Acquire Gerresheimer Rejected
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Silgan's Bid to Acquire Gerresheimer Rejected
Apr 17, 2026 4:15 AM

06:54 AM EDT, 04/17/2026 (MT Newswires) -- Silgan's ( SLGN ) bid to take over German medical packaging maker Gerresheimer has been rejected, Reuters reported Friday, citing sources familiar with the matter.

Talks between the two companies have concluded, the sources reportedly said.

Silgan ( SLGN ) made a non-binding offer of 41 euros ($48.36) per share, Reuters previously reported.

Silgan ( SLGN ) and Gerresheimer did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week
Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week
Apr 17, 2026
April 17 (Reuters) - Eli Lilly's ( LLY ) newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an analyst who cited IQVIA data. Novo Nordisk's oral Wegovy had hit 3,071 U.S. prescriptions in the first four days after its launch on January 5. Investors have been closely watching...
Lilly's Foundayo hits 1,390 prescriptions in debut week
Lilly's Foundayo hits 1,390 prescriptions in debut week
Apr 17, 2026
April 17 (Reuters) - Eli Lilly's ( LLY ) newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an analyst who cited IQVIA data. Novo Nordisk's oral Wegovy had hit 3,071 U.S. prescriptions in the first four days after its launch on January 5. ...
Bruker's Division Rolls Out MyGenius PRO Diagnostics System in Europe
Bruker's Division Rolls Out MyGenius PRO Diagnostics System in Europe
Apr 17, 2026
06:53 AM EDT, 04/17/2026 (MT Newswires) -- Bruker's ( BRKR ) Bruker Microbiology & Infection Diagnostics division said Friday it has rolled out molecular diagnostics system MyGenius PRO in Europe. The new diagnostics system is based on polymerase chain reaction, developed to diagnose infectious diseases, according to the division. Bruker Microbiology said the MyGenius PRO system automates the complete workflow...
Market Chatter: Silgan's Bid to Acquire Gerresheimer Rejected
Market Chatter: Silgan's Bid to Acquire Gerresheimer Rejected
Apr 17, 2026
06:54 AM EDT, 04/17/2026 (MT Newswires) -- Silgan's ( SLGN ) bid to take over German medical packaging maker Gerresheimer has been rejected, Reuters reported Friday, citing sources familiar with the matter. Talks between the two companies have concluded, the sources reportedly said. Silgan ( SLGN ) made a non-binding offer of 41 euros ($48.36) per share, Reuters previously reported....
Copyright 2023-2026 - www.financetom.com All Rights Reserved